Filing Details
- Accession Number:
- 0001213900-25-012684
- Form Type:
- 13G Filing
- Publication Date:
- 2025-02-11 19:00:00
- Filed By:
- Havlickova 648 a.s.
- Company:
- Cadrenal Therapeutics Inc.
- Filing Date:
- 2025-02-12
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Beneficially Owned Number of Shares | Beneficially Owned Number of Aggregate Shares | Percent of Class |
|---|---|---|---|
| Havlickova 648 a.s. | 0 | 78,291 | 4.39% |
| Dubnica Property s.r.o. | 0 | 78,291 | 4.39% |
| Miroslav Dornak | 0 | 78,291 | 4.39% |
Filing
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment No. 1)
|
Cadrenal Therapeutics, Inc. (Name of Issuer) |
Common Stock, par value $0.001 per share (Title of Class of Securities) |
127636207 (CUSIP Number) |
12/31/2024 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
 Rule 13d-1(c)
|
| Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. | 127636207 |
| 1 | Names of Reporting Persons
Havlickova 648 a.s. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
CZECH REPUBLIC
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
78,291.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
4.39 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
CO |
SCHEDULE 13G
|
| CUSIP No. | 127636207 |
| 1 | Names of Reporting Persons
Dubnica Property s.r.o. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
CZECH REPUBLIC
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
78,291.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
4.39 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
CO |
SCHEDULE 13G
|
| CUSIP No. | 127636207 |
| 1 | Names of Reporting Persons
Miroslav Dornak | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
CZECH REPUBLIC
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
78,291.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
4.39 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13G
|
| Item 1. | ||
| (a) | Name of issuer:
Cadrenal Therapeutics, Inc. | |
| (b) | Address of issuer's principal executive offices:
822 A1A North, Suite 306 Ponte Vedra, Florida 32082 | |
| Item 2. | ||
| (a) | Name of person filing:
Havlickova 648 a.s.
Dubnica Property s.r.o.
Miroslav Dornak
Collectively, the "Reporting Persons" | |
| (b) | Address or principal business office or, if none, residence:
Havlickova 648 a.s.
U Rustonky 714/1
186 00, Prague
Czech Republic
Dubnica Property s.r.o.
U Rustonky 714/1
186 00, Prague
Czech Republic
Miroslav Dornak
U Rustonky 714/1
186 00, Prague
Czech Republic | |
| (c) | Citizenship:
Havlickova 648 a.s. - Czech Republic
Dubnica Property s.r.o. - Czech Republic
Miroslav Dornak - Czech Republic | |
| (d) | Title of class of securities:
Common Stock, par value $0.001 per share | |
| (e) | CUSIP No.:
127636207 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
| |
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
| |
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
| |
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
| |
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
| |
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
| |
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
| |
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
| |
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
| |
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution: | |
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
| |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned:
Havlickova 648 a.s. - 78,291
Dubnica Property s.r.o. - 78,291
Miroslav Dornak - 78,291 | |
| (b) | Percent of class:
Havlickova 648 a.s. - 4.39%
Dubnica Property s.r.o. - 4.39%
Miroslav Dornak - 4.39% | |
| (c) | Number of shares as to which the person has:
| |
| (i) Sole power to vote or to direct the vote:
Havlickova 648 a.s. - 0
Dubnica Property s.r.o. - 0
Miroslav Dornak - 0 | ||
| (ii) Shared power to vote or to direct the vote:
Havlickova 648 a.s. - 78,291
Dubnica Property s.r.o. - 78,291
Miroslav Dornak - 78,291 | ||
| (iii) Sole power to dispose or to direct the disposition of:
Havlickova 648 a.s. - 0
Dubnica Property s.r.o. - 0
Miroslav Dornak - 0 | ||
| (iv) Shared power to dispose or to direct the disposition of:
Havlickova 648 a.s. - 78,291
Dubnica Property s.r.o. - 78,291
Miroslav Dornak - 78,291
The percentage of Shares reported to be beneficially owned by the Reporting Persons are based on 1,782,486 Shares of the Issuer outstanding as of December 18, 2024, based on information reported on the Issuer's prospectus supplement filed with the Securities and Exchange Commission (the "SEC") on December 20, 2024.
Havlickova 648 a.s. directly holds 78,291 Shares of the Issuer. Dubnica Property s.r.o. is the direct parent of Havlickova 648 a.s. and controls the voting and dispositive power of the 78,291 Shares of the Issuer held by Havlickova 648 a.s. Miroslav Dornak also controls the voting and dispositive power of the 78,291 Shares of the Issuer held by Havlickova 648 a.s. Accordingly, the Reporting Persons are treated as beneficially owning all of the 78,291 Shares of the Issuer directly held by Havlickova 648 a.s. | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
|
Ownership of 5 percent or less of a class
| ||
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|